TScan Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
TCRX
CUSIP
89854M101
Type
Equity
Class
COM
Num filings
29
Total reported value, excl. options
$20.3 M
Manager Report Date Value ($000) Shares Option Type